Business · 20/01/1995
FDA Revises Good Manufacturing Practice Regulations for Finished Pharmaceuticals
The FDA is updating its Good Manufacturing Practice (CGMP) regulations for finished human and veterinary pharmaceuticals, aiming to reduce regulatory burdens and clarify requirements for manufacturers.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →